Complications associated with sedative and neuromuscular blocking drugs in critically ill patients

Keyphrases

• Basic Pharmacology 33%
• Critically Ill 33%
• Critically Ill Patients 100%
• Direct Toxicity 33%
• Drug Class 33%
• Drug Delivery 33%
• Drug Selection 33%
• ICU Patients 33%
• ICU Setting 33%
• Indirect Toxicity 33%
• Long-term Administration 33%
• Myopathy 66%
• Nerve 33%
• Neuromuscular Blocking Agents 100%
• Neuromuscular Junction 33%
• Neuromuscular Recovery 33%
• Organ Dysfunction 33%
• Paresis 33%
• Pathophysiologic 33%
• Patient Comfort 33%
• Perioperative Period 33%
• Pharmacologic 33%
• Prolonged Use 33%
• Sedative 100%
• Skeletal muscle 33%
• Untoward Effect 33%

Medicine and Dentistry

• Muscle Innervation 33%
• Myopathy 66%
• Neuromuscular Blocking Agent 100%
• Neuromuscular Junction 33%
• Organ Dysfunction 33%
• Paresis 33%
• Patient Comfort 33%
• Perioperative Period 33%
• Sedative Agent 100%
• Skeletal Muscle 33%
• Weakness 66%

Pharmacology, Toxicology and Pharmaceutical Science

• Elimination 50%
• Myopathy 100%
• Neuromuscular Blocking Agent 100%
• Paresis 50%
• Weakness 100%